# Sickle Cell Disease Cure Initiative (SCDC)

> **NIH NIH OT2** · THE EMMES COMPANY, LLC · 2022 · $1,812,534

## Abstract

No Text

## Key facts

- **NIH application ID:** 10700477
- **Project number:** 3OT2HL142340-01S4
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** Victoria Hope Coleman-Cowger
- **Activity code:** OT2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,812,534
- **Award type:** 3
- **Project period:** 2017-09-30 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10700477

## Citation

> US National Institutes of Health, RePORTER application 10700477, Sickle Cell Disease Cure Initiative (SCDC) (3OT2HL142340-01S4). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10700477. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*